How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PB

NASDAQ:PBYI
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PB

Puma Biotechnology IncNASDAQ PBYI Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is PBYI undervalued compared to its fair value?

The fair value of PBYI stock is hidden USD. Relative to the market price of 3.71 USD Puma Biotechnology Inc is hidden.

Puma Biotechnology, Inc. is a biopharmaceutical company. The company is headquartered in Los Angeles, California and currently employs 192 full-time employees. The company went IPO on 2012-03-21. The firm is focused on t...[More about valuation]

Puma Biotechnology Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.191 $B

Price:

3.71 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.1

FINANCIALS

Puma Biotechnology financial for reporting period

Income Statement

0.044 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0048 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.044 B 100%
0.033 B 75%
-0.0023 B -5%
-0.0048 B -11%

Balance Sheet

0.21 B
0.051 B


Financial Position Analysis

Assets

0.21 B
Current Assets
0.14 B
Total non-current assets
0.071 B

Total current liabilities
0.098 B
Total non-current liabilities
0.065 B

Cash Flow Statement

0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Puma Biotechnology fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

35 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
32 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
7 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is PBYI attractive for investment based on fundamental analysis?

PBYI stock rating is hidden. Puma Biotechnology is a hidden by Eyestock methodology.

Get PBYI Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

7

Gross Margin:

73

CFO / Debt ratio:

hidden

Current ratio:

1.67

Debt / Equity ratio:

2.293

ROE:

35

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PBYI analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PBYI to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Puma Biotechnology Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Puma Biotechnology Inc dividends

PBYI dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PBYI stock

About the company Puma Biotechnology Inc

Market cap $B

0.191

Dividend yield

Shares outstanding

46.6413 B

Puma Biotechnology, Inc. is a biopharmaceutical company. The company is headquartered in Los Angeles, California and currently employs 192 full-time employees. The company went IPO on 2012-03-21. The firm is focused on the development and commercialization of products to enhance cancer care. The firm's lead product is NERLYNX, an oral version of neratinib, which is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the human epidermal growth factor receptors, HER1, HER2 and HER4. The company is primarily focused on the development and commercialization of the oral version of neratinib, and its advanced drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers. Its other products include PB272 (neratinib, intravenous), PB357, and certain related compounds. Its neratinib has clinical application in the treatment of several other cancers as well, including other tumor types that over-express or have a mutation in HER2 or epidermal growth factor receptor (EGFR), such as breast cancer, cervical cancer, lung cancer, or other solid tumors.

PBYI profile

  • Ticker

    PBYI

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    21 March 2012

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    192

  • City

    Los Angeles

  • Address

    Suite 2150, 10880 Wilshire Blvd.

  • Cusip

    74587V107